GlassScriptPhysician profile
Louise Ross Wannamaker
NPI 1366962144
$3,620.69
in general payments reported to CMS, 2019-2025
35 companies · $804 in 2025
The $804 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $298 · 2021: $204 · 2022: $451 · 2023: $632 · 2024: $606 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,041.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $529.33 | 2022-2025 | Veozah |
| Abbvie INC. | $521.86 | 2020-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $310.81 | 2022-2025 | |
| Hologic Sales and Service, LLC | $241.99 | 2019-2025 | Novasure |
| Daiichi Sankyo INC. | $192.72 | 2023-2025 | Injectafer |
| Pfizer INC. | $150.91 | 2021-2024 | |
| Sage Therapeutics, LLC | $131.09 | 2024-2025 | Zurzuvae |
| Astrazeneca Pharmaceuticals LP | $126.97 | 2019 | |
| Allergan, INC. | $125.00 | 2019 | |
| Clovis Oncology, INC. | $125.00 | 2019 | |
| Evofem Biosciences, INC. | $113.33 | 2021-2023 | Phexxi |
| Amniox Medical, INC. | $107.20 | 2019 | |
| Sumitomo Pharma America, INC. | $106.38 | 2024-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $90.78 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $88.39 | 2021-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $75.15 | 2021-2024 | Nexplanon |
| Therapeuticsmd, INC. | $69.48 | 2022 | |
| Optumhealth Care Solutions, LLC | $65.50 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Smith+Nephew, INC. | $60.27 | 2023-2025 | Pico, Grafix Pl, Renasys Go V2 Home |
| Octapharma USA, INC. | $44.65 | 2020 | |
| Meditrina | $41.34 | 2022-2025 | |
| Exact Sciences Corporation | $40.28 | 2023-2024 | Cologuard Collection Kit |
| Minerva Surgical, INC | $35.44 | 2024-2025 | |
| Millicent US INC | $33.89 | 2025 | Intrarosa, Femlyv |
| Novo Nordisk INC | $30.59 | 2025 | Wegovy |
| Coopersurgical, INC. | $27.44 | 2024 | Endosee |
| Genzyme Corporation | $16.74 | 2020 | |
| Lilly USA, LLC | $16.22 | 2020 | |
| Convatec INC. | $15.65 | 2021 | |
| Shield Therapeutics INC | $15.48 | 2023 | Accrufer |
| Aspira Women'S Health INC | $15.47 | 2023 | Ova1 |
| Lemaitre Vascular, INC. | $14.98 | 2024 | Artegraft Vascular Graft |
| Amag Pharmaceuticals, INC. | $13.84 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.51 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louise Wannamaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.